Akebia Therapeutics Inc.

NASDAQ: AKBA · Real-Time Price · USD
3.69
0.05 (1.37%)
At close: Jun 05, 2025, 3:59 PM
3.72
0.68%
After-hours: Jun 05, 2025, 07:56 PM EDT

Akebia Therapeutics Revenue

Akebia Therapeutics reported an annual revenue of $160.18M, reflecting a -17.7% growth. For the quarter ending March 31, 2025, Akebia Therapeutics generated $57.34M in revenue.
Revenue (ttm)
$160.18M
Revenue Growth
-17.7%
Price / Sales Ratio
2.5
Revenue / Employee
$884.97K
Employees
181
Market Cap
970.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.